Listen Now

Topics Covered

  • Updates from SABCS on the Treatment of ER, PR and HER2 Positive Breast Cancer
  • The Increasing Role of Diagnostic Testing in Informing Treatment Options
  • Investigational New Drugs in Clinical Trials
  • New Developments in the Management of Treatment Side Effects
  • Key Questions to Ask Your Health Care Team
  • Questions for Our Panel of Experts

Our Panel of Experts

Sara M. Tolaney, MD, MPH

Associate Director, Clinical Research, Breast Oncology, Susan F. Smith Center for Women’s Cancers, Senior Physician, Dana-Farber Cancer Institute, Assistant Professor of Medicine, Harvard Medical School

Roberto A. Leon-Ferre, MD

Assistant Professor, Department of Oncology, Mayo Clinic

Stacy Chilton, MSW

Women’s Cancers Program Coordinator, CancerCare


You can download the brochure for this workshop(pdf)(88.7 KB)

Workshop Date

This workshop was originally recorded on April 18, 2018.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.